Friday, October 30, 2020

Virtual program on treatment literacy on Hepatitis C held

Dimapur, October 17: With an objective of creating more awareness and treatment literacy with regard to the new treatment drugs for Viral Hepatitis C (HCV), ARK Foundation with support from the Social Welfare Department collaborated with Zion Welfare Society, Wokha, KBCA, Noklak and DAPCU, Kiphire conducted a series of virtual programs under the banner, “Treatment Literacy on hepatitis C” with injecting drug users and staff of the NGOs on October 10, 15 and 16 respectively.
The participants of the workshop included injecting drug users and NGO staff, where Ketho Angami, President, ARK Foundation facilitated the program as the resource person. The sessions covered during the program included Hepatitis as a disease of the Liver, Its routes of transmission, test and diagnostics and treatment with the new oral regimens known as directly acting antivirals (DAAs) under the National Viral Hepatitis Control Program (NVHCP).
The program started with Ketho sharing the objectives of the workshop and the need to put special emphasis on the need for the drug using community, since it is preventable and curable.
He made a presentation stating that Hepatitis is a general term for swelling (inflammation) of the liver which can be caused by many due to drinking a lot of alcohol, taking certain medications or herbs, inhaling toxic fumes, viral hepatitis infections, or contacts with contaminated urine, water, soil or food).
It was followed by a presentation on the nature of HCV testing which starts initially with the antibody test followed by a series of other diagnostic test and monitoring test during treatment.
The participants were informed on the new treatment drugs namely Sofosbuvir in combination with Daclatasvir or Velpatasvir with the Genotype test not a requisite anymore. This is so because the new drugs called DAAs works across all the genotype and treatment period is ideally for a three months course. These drugs shows treatment cure rate as high as 96% with minimal side effects.
Ketho concluded the program by thanking the partner NGOs for jointly organising the program and also thanked the Social Welfare Department for their support. (Page News Service)